The company has passed GB/T 1900 1:2008 quality management system standard, GB/T2400 1:2004 environmental management system standard and GB/T 2800 1: 20 1. It is the key leading enterprise of agricultural industrialization in Gansu Province, the vice-chairman unit of Gansu Longyao Pharmaceutical Industry Association, the vice-chairman unit of Chinese herbal medicine planting professional committee of China Chinese Medicine Association, the vice-chairman unit of Gansu Pharmaceutical Industry Association, the director unit of Gansu Chinese herbal medicine industry association, the vice-chairman unit of Northwest natural medicine (China Tibetan medicine) industrial technology innovation strategic alliance, and a high-tech certification enterprise. Approved the establishment of a provincial engineering center (engineering laboratory)-Gansu Province characteristic medicinal plant resources protection and utilization engineering laboratory. The brand products of "Zhongtian Teke" and "Longshan Weishui" produced by the company were awarded the gold medal in Gansu Province. It has obtained 19 patents, among which "Gentiana macrophylla greenhouse seedling raising and plastic film mulching cultivation technology" won the first prize in the first Gansu Youth Innovation Action Science and Technology Invention and Production category. 20 10 is listed as one of the six leading enterprises in the development of Chinese herbal medicines by the provincial party Committee and government.
The wholly-owned subsidiaries are Gansu Zhongtian Jindan Pharmaceutical Co., Ltd., Gansu Long Yuan Zhongtian Logistics Co., Ltd. and Zhongtian Pharmaceutical Research Institute. The company's products include Chinese herbal medicines, Chinese herbal pieces, Chinese herbal health products, native products and gifts, Chinese herbal extracts, Chinese patent medicines, health foods and other products.
Brief introduction of Zhongtian pharmaceutical research institute, a wholly-owned subsidiary
Zhongtian Pharmaceutical Research Institute consists of office, project department, research department of medicinal plants, processing research department of traditional Chinese medicine, extraction research department of traditional Chinese medicine, pharmaceutical research department, pharmacology and toxicology research department, clinical trial research department, pilot laboratory of traditional Chinese medicine and information research department of traditional Chinese medicine. We have established long-term cooperative relations with many universities and scientific research institutions, established provincial enterprise technology centers, and undertaken the work of the engineering laboratory for the protection and utilization of characteristic medicinal plant resources in Gansu Province. Mainly engaged in the development and research of various new drug varieties; Research on technological innovation of production technology; Industrialization research of new products and technologies; Study on germplasm resources and storage technology of Chinese herbal medicines: development of health food.
Brief introduction of Gansu Long Yuan Zhongtian Logistics Co., Ltd., a wholly-owned subsidiary
Founded in 2008, the company has a registered capital of 60 million yuan and total assets of nearly 200 million yuan. 20 10 passed the national drug GSP certification in July, and it is the executive director unit of Gansu Logistics Association. Longxi Traditional Chinese Medicine Logistics Park built by the company is located in the center of Longxi Traditional Chinese Medicine Circular Economy Industrial Park, with exhibition center, information center, distribution center, storage center, testing center, comprehensive office building and large parking lot.
Brief introduction of Gansu Zhongtian Jindan Pharmaceutical Co., Ltd., a wholly-owned subsidiary
The company is located in Nidu-Jinchang National Economic and Technological Development Zone, covering an area of 46,072 square meters and a building area of 7,244 square meters, with a registered capital of 20.5 million yuan and existing assets of 56,765,438+10,000 yuan. It has five GMP-certified production lines for tablets, powders, capsules, granules and mixtures, and is equipped with Chinese herbal medicine pretreatment workshop, extraction workshop, oral solid preparation workshop, oral liquid preparation workshop, powder workshop, central laboratory and new product research and development center. The annual output can reach 654.38+0 billion tablets, 654.38+0 billion capsules, 654.38+0 billion bags of granules, 654.38+0 billion bags of powders and 654.38+0.2 billion tablets of mixtures. There are 46 varieties of ethnic medicines with quasi-brand names, including tablets, powders, capsules, granules, mixtures and other dosage forms. Among them, Hongqi Oral Liquid is the national exclusive OTC drug quasi-brand name, which is an excellent new product (new technology) in Gansu Province, filling the blank of Radix Hedysari without preparation medicine in Gansu Province and also filling the blank of Radix Hedysari without fist product in Gansu Province. In May 2005, it was listed as a national torch plan project by the Ministry of Science and Technology.
Second, product introduction
Chinese herbal pieces: mainly producing more than 600 kinds of Chinese herbal pieces, including direct oral Chinese herbal pieces, conventional Chinese herbal pieces and toxic Chinese herbal pieces; A total of 10 kinds of decoction pieces were produced, including Radix Astragali, Radix Codonopsis, Radix Angelicae Sinensis, Radix et Rhizoma Rhei, Radix Bupleuri, Radix Isatidis, Radix Scutellariae, Radix Glycyrrhizae, etc.
Traditional Chinese medicine health products: mainly produce health tea, health meal, health soup, health decoction pieces and other products.
Native products gift series: produce native products gift series representing local resources and culture. Including real estate series (ordinary clothes, fine clothes), health products gifts (health tea, etc.). ), health care products gifts.
Traditional Chinese Medicine Extracts: In addition to meeting the downstream product demand of the company, it also provides semi-finished products for pharmaceutical enterprises to produce traditional Chinese medicine extracts such as Radix Astragali, Radix Angelicae Sinensis and Radix Glycyrrhizae. According to the needs of users, we can contract the processing of plant active ingredient extracts.
Chinese patent medicine: there are tablets, capsules, granules, syrups, oral liquids, mixtures, tinctures, fluid extracts, extractives, etc., and there are 46 kinds of traditional Chinese medicines with quasi-brand names, such as Fuyang granules, Xiaoer Kechuanling granules, Shangke Da Die tablets, Maxing Zhike tablets, Fukangling tablets, Yigan Fuzheng capsules, Tongbianling capsules, Shen Ling Baizhu powder, Jianer Xiaoshi oral liquid, Hongqi oral liquid, etc. The new drugs being studied are new drugs for treating gastroesophageal reflux disease, Guzhitong Granule and Jiangzhi Granule.
Health food: there are tablets, capsules, granules, syrups, oral liquids and other dosage forms. Has owned national food brands such as Qishen Capsule and Intestinal Adhesion Capsule. Products under research include Zhongtian Huangqi Shenqi Granule, Sanye Jiangtang Tea, Qizhi Capsule and Qiju Cassia Capsule.
Three. Technology and R&D
The company's new product development adopts the combination of independent development and cooperative development with universities and scientific research units (Institute of Traditional Chinese Medicine, Chinese Academy of Traditional Chinese Medicine, Nanjing University of Traditional Chinese Medicine, Lanzhou University, Gansu College of Traditional Chinese Medicine and Gansu Agricultural University). The company has advanced experimental testing instruments and mature pilot conditions. As the main force of the company's internal product development, the company's pharmaceutical research institute has 65,438+00 full-time researchers, including 6 senior titles, and fully mobilizes technical forces in production, quality inspection and engineering to participate in new product development. Has obtained 19 patents. "Cultivation techniques of Gentiana macrophylla covered with plastic film in greenhouse" won the first prize of the first Gansu Youth Innovation Action Science and Technology Invention and Production category.
Fourth, the whole industrial chain of Zhongtian traditional Chinese medicine
The company's all-Chinese medicine industry chain development model centered on the construction of medicine source base-based on the construction of base, based on the trade of real estate medicinal materials, supplemented by Chinese medicine decoction pieces and dietotherapy decoction pieces, and guided by Chinese patent medicines and health food.
The whole industrial chain model of traditional Chinese medicine is the company's outstanding competitive advantage. The upstream of the company integrates medicinal resources to strengthen the competitiveness of medicinal materials producing areas; Processing in the middle reaches, promoting the intensive processing of Chinese herbal medicines, arranging Chinese herbal pieces, Chinese herbal extracts, health foods and proprietary Chinese medicines, and refining industrial chain products; Create a comprehensive value-added service provider for modern Chinese herbal medicine trade logistics platform; Use the advantages of comprehensive information technology in the market to steadily increase the trade of Chinese herbal medicines; Downstream through retail pharmacies, Chinese medicine hospitals and other channels, set foot in consumer terminals, to achieve Chinese medicine and medical services in industry consolidation.